| RNA-binding protein Musashi1 is a central regulator of adhesion pathways in glioblastoma PJ Uren, DT Vo, PR de Araujo, R Pötschke, SC Burns, E Bahrami-Samani, ... Molecular and cellular biology 35 (17), 2965-2978, 2015 | 64 | 2015 |
| IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis J Haase, D Misiak, M Bauer, N Pazaitis, J Braun, R Pötschke, A Mensch, ... Modern Pathology 34 (1), 32-41, 2021 | 31 | 2021 |
| KLF4K409Q–mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment N von Spreckelsen, N Waldt, R Poetschke, C Kesseler, H Dohmen, ... Acta neuropathologica communications 8, 1-11, 2020 | 28 | 2020 |
| Musashi1 enhances chemotherapy resistance of pediatric glioblastoma cells in vitro R Pötschke, G Gielen, T Pietsch, C Kramm, JH Klusmann, S Hüttelmaier, ... Pediatric Research 87 (4), 669-676, 2020 | 14 | 2020 |
| MSI1 promotes the expression of the GBM stem cell marker CD44 by impairing miRNA-dependent degradation R Pötschke, J Haase, M Glaß, S Simmermacher, C Misiak, LOF Penalva, ... Cancers 12 (12), 3654, 2020 | 11 | 2020 |
| DIPG-26. Targeted Protein Degradation of LSD1 synergizes with HDAC inhibitors in Diffuse Intrinsic Pontine Glioma A Groves, R Poetschke, H Mire, E Panditharatna, MT Guzman, J Qi, ... Neuro-oncology 24 (Suppl 1), i24, 2022 | 2 | 2022 |
| DIPG-53. LSD1 DEGRADATION SYNERGIZES WITH HDAC INHIBITION IN PEDIATRIC H3K27M DIFFUSE MIDLINE GLIOMA R Haase, A Groves, H Mire, J Qi, M Filbin Neuro-Oncology 25 (Suppl 1), i25, 2023 | | 2023 |
| HGG-25. TARGETED DRUGS SYNERGIZE WITH DOUBLE ALKYLATOR THERAPY IN H3. 3 G34R/V PEDIATRIC HIGH-GRADE GLIOMA R Haase, A Green, L Kilburn, M Filbin Neuro-Oncology 25 (Suppl 1), i45, 2023 | | 2023 |
| HGG-05. PERTURBING GABAERGIC NEURONAL LINEAGE IN DIFFUSE HEMISPHERIC GLIOMA, H3G34-MUTANT, HIGHLIGHTS CDK6 AS A CLINICALLY ACTIONABLE TARGET I Liu, GAV Cruzeiro, L Bjerke, R Rogers, Y Grabovska, A Beck, A Mackay, ... Neuro-Oncology 25 (Supplement_1), i39-i39, 2023 | | 2023 |
| Unraveling the role of the RNA-binding protein MUSASHI1 in chemoresistance and malignancy of Glioblastoma R Pötschke | | 2020 |
| CBMT-25. THE KLF4K409Q MUTATION IN MENINGIOMA IMPAIRS HIF-1Α DEGRADATION AND CAN BE HARNESSED FOR TARGETED THERAPY N von Spreckelsen, N Waldt, R Poetschke, C Kesseler, H Dohmen, ... Neuro-Oncology 21 (Suppl 6), vi38, 2019 | | 2019 |
